Purpose: The aim of this study was to review published studies to identify and describe barriers to Papanicolaou (Pap) smear screening among women in sub-Saharan Africa.
Design And Methods: Guided by Cooper's integrative review methodology, studies published between 2006 and 2015 were identified by searching electronic databases: Cumulative Index to Nursing and Allied Health Literature (CINAHL), PubMed, MEDLINE, ProQuest, and PsycINFO using specified search terms. Using this strategy, 224 articles were identified and screened for duplication and by reading titles, abstracts, and full texts. Seventeen articles met the inclusion criteria and were appraised using relevant tools for qualitative and quantitative designs. No relevant articles published in 2006, 2007, and 2014 were found.
Findings: All 17 articles had good methodological quality and were included in the review. The studies were from 10 sub-Saharan countries and from different settings. Content analysis of the data revealed three major themes coded as client, provider, and system barriers. The most common client barriers were lack of knowledge and awareness about Pap smear screening, fear of cancer, belief of not being at risk for cervical cancer, and that a Pap smear is not important unless one is ill and cultural or religious factors. Provider barriers were failure to inform or encourage women to screen. Major system barriers were unavailability and inaccessibility of the Pap test.
Conclusions: The review provided evidence of barriers to Pap smear screening among sub-Saharan women. Although there were some variations from country to country, sub-Saharan countries share similar constraints to Pap smear screening. These findings have important implications for practice and policy.
Clinical Relevance: Understanding the client, provider, and system barriers to cervical cancer screening could guide development of effective interventions.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/jnu.12232 | DOI Listing |
Cureus
December 2024
Research, Orlando College of Osteopathic Medicine, Winter Garden, USA.
The Pap smear is widely recognized in medicine as the single most successful contributor to cancer screening and preventative care. Women have Dr. George Papanicolaou (1870-1962) to thank for this groundbreaking contribution to their healthcare-a discovery that, fascinatingly, was made incidentally during his study of ovulation cycles in guinea pigs.
View Article and Find Full Text PDFSci Rep
January 2025
Research Institute for Applied Microelectronics (IUMA), University of Las Palmas de Gran Canaria (ULPGC), Las Palmas de Gran Canaria, Spain.
Cervical cancer remains a major global health concern, with a specially alarming incidence in younger women. Traditional detection techniques such as the Pap smear and colposcopy often lack sensitivity and specificity and are highly dependent on the experience of the gynaecologist. In response, this study proposes the use of Hyperspectral Imaging, a pioneering technology that combines traditional imaging with spectroscopy to provide detailed spatial and spectral information.
View Article and Find Full Text PDFPLOS Glob Public Health
December 2024
Department of Medical Laboratory Sciences, University of Health and Allied Sciences, Ho, Ghana.
Cervical cancer is a recognized preventable disease yet the fourth most common cancer among women globally. This study assessed the integration and acceptability of cervical cancer screening as part of routine sixth-week postnatal care among women attending a postnatal clinic. This was a cross-sectional descriptive study among 347 postpartum women who were attending their 6th-week postnatal visit.
View Article and Find Full Text PDFInt J Behav Med
December 2024
The Nethersole School of Nursing, The Chinese University of Hong Kong, Hong Kong SAR, China.
Background: Young working women who devote most of their time to jobs and household chores may experience conflicts when faced with a cervical cancer screening decision. This study aimed to assess the acceptability and feasibility of a Web-based decision aid on cervical cancer screening by young working women, and to preliminarily examine the effects of the decision aid on the knowledge level, risk perception, decisional conflicts, screening decision and screening uptake.
Method: This was a pilot randomised controlled trial.
Sci Rep
December 2024
Decisions LAB, Department of Law, Economics and Human Sciences, University Mediterranea of Reggio Calabria, Via dei Bianchi, 2, 89131, Reggio Calabria, Italy.
Cervical cancer is one of the deadly diseases that affects women, which requires periodic examinations to identify and treat any cancerous tumors at a preliminary stage. The most prevalent examination tool for cervical cancer prompt identification is the cervical smear (Pap smear) testing; however, due to human negligence, this examination method has an elevated probability of negative findings. Cervical cancer classification using machine learning (ML) and deep learning (DL) has been extensively studied to enhance the conventional diagnostic process.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!